The LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire based FFR revascularization.

Summary

LIPSIA- STRATEGY evaluated whether revascularization guided by angiography based FFR using CAAS vFFR (vessel fractional flow reserve), provides clinical outcomes comparable to guidance by pressure wire based FFR.